Objectives: To evaluate the proficiency of a HIPAA-compliant version of GPT-4 in identifying actionable, incidental findings from unstructured radiology reports of Emergency Department patients. To assess appropriateness of artificial intelligence (AI)-generated, patient-facing summaries of these findings.

Materials And Methods: Radiology reports extracted from the electronic health record of a large academic medical center were manually reviewed to identify non-emergent, incidental findings with high likelihood of requiring follow-up, further sub-stratified as "definitely actionable" (DA) or "possibly actionable-clinical correlation" (PA-CC). Instruction prompts to GPT-4 were developed and iteratively optimized using a validation set of 50 reports. The optimized prompt was then applied to a test set of 430 unseen reports. GPT-4 performance was primarily graded on accuracy identifying either DA or PA-CC findings, then secondarily for DA findings alone. Outputs were reviewed for hallucinations. AI-generated patient-facing summaries were assessed for appropriateness via Likert scale.

Results: For the primary outcome (DA or PA-CC), GPT-4 achieved 99.3% recall, 73.6% precision, and 84.5% F-1. For the secondary outcome (DA only), GPT-4 demonstrated 95.2% recall, 77.3% precision, and 85.3% F-1. No findings were "hallucinated" outright. However, 2.8% of cases included generated text about recommendations that were inferred without specific reference. The majority of True Positive AI-generated summaries required no or minor revision.

Conclusion: GPT-4 demonstrates proficiency in detecting actionable, incidental findings after refined instruction prompting. AI-generated patient instructions were most often appropriate, but rarely included inferred recommendations. While this technology shows promise to augment diagnostics, active clinician oversight via "human-in-the-loop" workflows remains critical for clinical implementation.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11339516PMC
http://dx.doi.org/10.1093/jamia/ocae117DOI Listing

Publication Analysis

Top Keywords

actionable incidental
12
incidental findings
12
patient instructions
8
radiology reports
8
ai-generated patient-facing
8
patient-facing summaries
8
findings
7
gpt-4
6
evaluation gpt-4
4
gpt-4 ability
4

Similar Publications

Opportunistic genomic screening has clinical utility: An interventional cohort study.

Genet Med

November 2024

Institute of Health Policy, Management & Evaluation, University of Toronto, Toronto, Ontario, Canada; Genomics Health Services Research Program, Li Ka Shing Knowledge Institute, St Michael's Hospital, Unity Health Toronto, Toronto, Ontario, Canada.

Background: Practice is shifting toward genome-first approaches, such as opportunistic screening for secondary findings (SFs). Analysis of SFs could be extended beyond medically actionable results to include non-medically actionable monogenic disease risks, carrier status, pharmacogenomic variants, and risk variants for common complex disease. However, evidence on the clinical utility of returning these results is lacking.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how often MRI scans reveal unexpected but clinically significant findings in patients with knee osteoarthritis (KOA) suspected of having meniscal tears.
  • Out of 760 subjects who underwent MRIs, 61 (8.03%) were found to have notable findings such as subchondral insufficiency fractures, avascular necrosis, and tumors.
  • The results suggest that clinicians should consider a broader range of potential conditions underlying knee symptoms, as these incidental findings may require different management approaches and further imaging.
View Article and Find Full Text PDF

Classification and Communication of Critical Findings in Emergency Radiology: A Scoping Review.

J Am Coll Radiol

September 2024

Ottawa Hospital Research Institute, Ottawa, Canada, and Department of Emergency Medicine, The Ottawa Hospital, Ottawa, Canada; Assistant Directory, Quality Improvement and Patient Safety Program.

Purpose: To identify the published standards for the classification and communication of critical actionable findings in emergency radiology and the associated facilitators and barriers to communication and message management or dissemination of such findings.

Materials And Methods: Search terms for resources pertaining to critical findings (CFs) in emergency radiology were applied to two databases (PubMed, Embase). Screening of hits using the following pre-established inclusion and exclusion criteria were performed by three analysts with subsequent consensus discussion for discrepancies: (1) the resources include any standards for the classification and communication of imaging findings as critical, or (2) the resource discusses any facilitators to the communication of CFs, or (3) the resource discusses any barriers to the communication of CFs.

View Article and Find Full Text PDF

International policies guiding the selection, analysis, and clinical management of secondary findings from genomic sequencing: A systematic review.

Am J Hum Genet

October 2024

Institute of Health Policy, Management, and Evaluation, University of Toronto, Toronto, ON, Canada; Genomics Health Services Research Program, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada; Genetics Adviser, Toronto, ON, Canada. Electronic address:

Article Synopsis
  • Secondary findings (SFs) from genomic sequencing can greatly affect patient health, but guidelines for their clinical investigation are inconsistent, prompting a review of existing policies.
  • The review encompassed 63 SF policies from various international sources, focusing on SFs selection, analysis, and clinical management, and revealed that most guidelines address clinical management while fewer tackle selection and analysis.
  • Although policies scored well for scope and clarity, they fell short in rigor and applicability, indicating a need for improved practices in SFs analysis, clinical validation, and follow-up support to ensure evidence-based care.
View Article and Find Full Text PDF

Assessing actionability and incidental findings of germline variants in two precision oncology trials.

Eur J Cancer

October 2024

Cancer Genetics Laboratory, Medical Biology and Pathology Department, Gustave-Roussy Cancer Campus, Villejuif, France.

Introduction: High-throughput sequencing techniques have revolutionized oncology. Paired germline-tumor DNA analysis has emerged as a comprehensive strategy to uncover actionable alterations in advanced cancer patients (ACP) enrolled in precision oncology trials. However, challenges persist in variant interpretation and managing incidental germline findings.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!